Key result
In mice, ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL.
Answers are grounded in this paper and cite their sources.
Preclinical distinction of ACAT2 and LCAT in mice warrants no practice change; leaves open human relevance for lipoprotein-targeted therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2005) studied this question. ACAT2 and LCAT deficiency was evaluated on Cholesteryl ester (CE) content of VLDL and LDL. In mice, ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL.
Synapse has enriched 10 related papers. Consider them for comparative context: